Also trades as: 0LO4.L (LSE) · $vol 0M

$83.33

-4.09 (-4.68%)

Weekly Expected Move ±3.4%

$81 $84 $87 $90 $93

NYSE · Real Estate · REIT - Healthcare Facilities · Tech Score Neutral · Power 59 · $42.7B mcap · 510M float · 0.715% daily turnover · Short 51% of daily vol

Credit Risk of going bust: not rated, financial company (lending is its business) Bonds: $222.3M held by 238 funds, 63 bp over Treasuries → details ▾

Not rated: lending and leverage are a financial company's business, which the model misreads.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue

$5.8B +18.5% ▲

5Y CAGR: +9.0%

Gross Profit

-$344M -116.4% ▼

Operating Income

$827M +21.4% ▲

5Y CAGR: +6.9%

Net Income

$251M +209.8% ▲

5Y CAGR: -10.6%

EPS (Diluted)

$0.54 +184.2% ▲

5Y CAGR: -14.3%

EBITDA

$2.2B +15.6% ▲

5Y CAGR: +2.9%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$3.8B	$4.1B	$4.5B	$4.9B	$5.8B
YoY Growth	+0.9%	+7.9%	+8.9%	+9.5%	+18.5%
Cost of Revenue	$2.1B	$2.3B	$2.6B	$2.8B	$6.2B
Gross Profit	$1.7B	$1.8B	$1.9B	$2.1B	-$344M
Gross Margin	45.4%	44.7%	43.1%	42.6%	-5.9%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$130M	$145M	$149M	$163M	$177M
Operating Expenses	$1.3B	$1.4B	$1.5B	$1.4B	-$1.2B
Operating Income	$421M	$484M	$416M	$681M	$827M
Operating Margin	11.0%	11.7%	9.2%	13.8%	14.2%
Interest Expense	$440M	$468M	$574M	$603M	$612M
Income Before Tax	$61M	-$58M	-$40M	$51M	$247M
Tax Expense	$5M	-$17M	-$10M	-$38M	-$14M
Net Income	$49M	-$47M	-$41M	$81M	$251M
Net Margin	1.3%	-1.1%	-0.9%	1.6%	4.3%
EPS (Diluted)	$0.13	$-0.13	$-0.10	$0.19	$0.54
EBITDA	$1.7B	$1.6B	$1.9B	$1.9B	$2.2B
Shares Outstanding	386M	373M	406M	416M	463M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$1.2B	$1.3B	$1.4B	$1.4B	$1.5B	$1.6B	$1.7B	$1.7B
Cost of Revenue	$715M	$741M	$786M	$827M	$870M	$3.7B	$1.0B	$1.0B
Gross Profit	$521M	$546M	$572M	$594M	$619M	-$2.1B	$655M	$689M
Gross Margin	42.2%	42.4%	42.1%	41.8%	41.6%	-136.0%	39.6%	39.8%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$35M	$41M	$53M	$43M	$40M	$41M	$63M	$47M
Operating Expenses	$339M	$350M	$375M	$391M	$398M	-$2.3B	$464M	$473M
Operating Income	$182M	$196M	$198M	$203M	$222M	$204M	$192M	$216M
Operating Margin	14.7%	15.2%	14.6%	14.3%	14.9%	13.0%	11.6%	12.5%
Interest Expense	$150M	$153M	$149M	$150M	$300M	$154M	$156M	$160M
Income Before Tax	$24M	$13M	$38M	$75M	$62M	$72M	$43M	$50M
Tax Expense	$3M	-$46M	-$11M	$4M	-$6M	-$1M	-$16M	-$26M
Net Income	$19M	$57M	$47M	$68M	$66M	$70M	$56M	$74M
Net Margin	1.6%	4.4%	3.5%	4.8%	4.4%	4.5%	3.4%	4.3%
EPS (Diluted)	$0.05	$0.13	$0.11	$0.15	$0.14	$0.15	$0.11	$0.14
EBITDA	$486M	$466M	$516M	$580M	$586M	$557M	$730M	$632M
Shares Outstanding	419M	428M	446M	459M	463M	481M	487M	492M

VTR NYSE